Written on: November 6, 2024 by SprayTM
Kenvue Inc. announced the appointment of Andrew Stanleick to the role of President, Skin Health & Beauty for North America and Europe, Middle East & Africa (EMEA), leading the strategic direction of the company’s portfolio of brands such as Neutrogena, Aveeno and OGX, in the regions.
STANLEICK
“We are very pleased to have Andrew join Kenvue in this critical role,” said Charmaine England, Chief Growth Officer, Kenvue.
“With over two decades of experience in leading the profitable growth and omni-channel transformation of global multi-brand portfolios in skin health, beauty and fashion, Andrew brings a proven track record of success and deep industry knowledge to strengthen the growth trajectory of our Skin Health & Beauty segment in key markets,” Englad continued.
Added Stanleick, “I am thrilled to join the Kenvue team at such an exciting time for the company. I look forward to helping these brands reach more consumers in new ways in 2025 and beyond.”
Prior to joining Kenvue, Stanleick served as the President & CEO of BeautyHealth Co., known for its flagship skin health brand, HydraFacial. Before joining BeautyHealth, he served as the Executive VP of Coty Americas, overseeing their portfolio of luxury and consumer brands, including COVERGIRL, across the region. He also served as the Global CEO for the joint venture with Kylie Jenner Beauty and oversaw the Kim Kardashian business. Earlier in his career, he spent several years as President & CEO of Coach Inc., Europe and South Asia & Pacific, as well as held senior marketing and country management leadership roles across multiple channels and categories at Unilever and L’Oreal.
In other company news, Kenvue Canada announced the completion of its newly expanded manufacturing facility in Guelph, Ontario. The facility has been the home to the Canadian arm of Kenvue’s manufacturing footprint since 1978. The facility manufactures more than 100 different medications, such as Motrin, Benylin, Sudafed and the majority of the Tylenol available in Canada.
